Top Life Sciences Startups in 2027

Knowtions Research developed Lydia, an AI platform that helps insurers unlock and use predictive insights into messy health data. Lydia learns how people seek medical care globally to make predictions on fraudulent behavior and health risks. Insurers use these predictions to create AI-assisted workflows that automate claims processing and personalize the customer experience.

We use synthetic biology to make biosensor plants. Our plants detect fungi, insect, and general stress within hours of infection and generate an artificial signal that is read via remote sensor technologies. Our customers are companies in the grain supply chain from agro-chemical companies, to growers, all the way to food processors.

Revance is a commercial stage biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.

Sema4 is a next-generation health information company, spun out of the Mount Sinai Health System, that provides advanced genomic testing and merges big data analytics with clinical diagnostics. Our team creates practical tools that help patients, clinicians, and researchers better diagnose, treat, and prevent disease. We are striving to construct a more comprehensive picture of health by integrating three key elements: a wealth of clinical experience that informs the answers that patients and providers are seeking, the world-class academic research that illuminates new directions, and the pioneering information science that puts all the pieces together.

Intelligent Digital Drug Discovery and Development (ID4) platform, which provides - Crystal Structure Prediction - Computation of Relative Free energies - Solubility predictions - Prediction of Nucleation Conditions for Crystal Structures for biotechnology and pharmaceutical clients

Curi Bio is innovating at the intersection of human stem cells, tissue-specific biosystems, and AI/ML-enabled data analytics. Curi helps scientists and drug developers create highly mature, predictive iPSC-derived cell models, innovative biosystem designs that enable high-throughput clinically-relevant readouts, and phenotypic screening using deep learning techniques for cell-based assay insights.

Our CapsidMap™ platform uses AI to systematically and rapidly optimize AAV capsids, overcoming the limitations of naturally occurring virus capsids by improving targeting ability, payload size, immune evasion and manufacturability. By building a massive and detailed map of synthetic AAV capsid sequence space, we can quickly navigate the landscape to find enhanced gene therapy vectors with transformative potential.

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology

Our Company: Genista Biosciences is a rapidly growing biotech company based in San Jose, CA that is dedicated to improving public health and food safety, both on the community and global scale. Our Goal: To revolutionize food safety by creating a cutting-edge platform based on a unique combination of robotics, software, and technology. Our ability to offer fast and accurate testing while still being cost-effective allows every member of the food supply chain (big or small) to be rest assured that the food they produce is safe thereby making the world a better place.

Platform that can be customized for a variety of research purposes - clinical document abstraction, Mass Spec repository, longitudinal study data management